Chronic Granulotomous Disease

Data are from a placebo controlled trial of gamma interferon in chronic granulotomous disease (CGD). Uses the complete data on time to first serious infection observed through end of study for each patient, which includes the initial serious infections observed through the 7/15/89 interim analysis data cutoff, plus the residual data on occurence of initial serious infections between the interim analysis cutoff and the final blinded study visit for each patient. Only one patient was taken off on the day of his last infection.

sample SAS code to read the data
sample S-Plus code to read the data

Reference: Fleming and Harrington, Counting Processes and Survival Analysis, appendix D.2.